A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy

ClinicalTrials.gov ID: NCT04015141

Public ClinicalTrials.gov record NCT04015141. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 10:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Study With Extension Phase to Evaluate the Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Subjects (Age 1 Month to Less Than 18 Years) With Childhood Epilepsy

Study identification

NCT ID: NCT04015141
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Eisai Inc.; Industry
Enrollment: 100 participants

Conditions and interventions

Conditions

Interventions

Perampanel Oral Suspension Drug
Perampanel Tablet Drug

Drug

Eligibility (public fields only)

Age range: 1 Month to 18 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 30, 2019
Primary completion: Apr 5, 2027
Completion: Dec 22, 2027
Last update posted: Oct 8, 2025

2019 – 2027

United States locations

U.S. sites: 22
U.S. states: 15
U.S. cities: 22

Facility	City	State	ZIP	Site status
Phoenix Childrens Hospital	Phoenix	Arizona	85016	Withdrawn
Center For Neurosciences	Tucson	Arizona	85718	Withdrawn
David Geffen School of Medicine at UCLA	Los Angeles	California	90095	Recruiting
Childrens Hospital Colorado	Aurora	Colorado	80045	Active, not recruiting
Nemours Foundation Alfred Dupont Children's Hospital	Wilmington	Delaware	19803	Withdrawn
Nicklaus Children's Hospital	Miami	Florida	33155	Terminated
Pediatric Neurology PA	Orlando	Florida	32819	Withdrawn
Pediatric Epilepsy and Neurology Specialists	Tampa	Florida	33607	Recruiting
PANDA Neurology	Atlanta	Georgia	30328	Withdrawn
Meridian Clinical Research-(Savannah Georgia)	Savannah	Georgia	31406	Completed
Children's Hospital of Michigan	Detroit	Michigan	48201	Completed
Northeast Regional Epilepsy Group	Hackensack	New Jersey	07601	Completed
Columbia University Medical Center	New York	New York	10032	Withdrawn
Wake Forest Baptist Medical Center - PPDS	Winston-Salem	North Carolina	27157	Active, not recruiting
University Hospitals Cleveland Medical Center	Cleveland	Ohio	44106	Completed
Dayton Children's Hospital	Dayton	Ohio	45404	Completed
Doernbecher Children's Hospital	Portland	Oregon	97239	Withdrawn
Child Neurology Consultants of Austin	Austin	Texas	78731	Completed
Road Runner Research Ltd	San Antonio	Texas	78249	Recruiting
Children's Specialty Group	Norfolk	Virginia	23510	Completed
Children's Hospital of Richmond at VCU - CHoR-PIN	Richmond	Virginia	23298	Completed
Seattle Children's Hospital	Seattle	Washington	98105	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04015141, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 8, 2025 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04015141 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →